Gomintia
Gomintia is a medicine authorised by Swissmedic under authorisation number 70542. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 December 2025 and the authorisation is valid without a time limit. ATC code L04AB06 places the medicine in the group Immunosuppressants.
| Authorisation number | 70542 |
|---|---|
| Name | Gomintia |
| Full name | Gomintia, Injektionslösung im Fertigpen 50 mg/0.5 ml |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AB06 |
| First authorisation | 09 December 2025 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gomintia, Injektionslösung im Fertigpen 50 mg/0.5 ml | B | 09 December 2025 |
| 2 | Gomintia, Injektionslösung im Fertigpen, 100 mg/1 ml | B | 09 December 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Injektor(en), vorgefüllt/Pen | L04AB06 | 07.15.0. | B |
| 2 | 1 | Injektor(en), vorgefüllt/Pen | L04AB06 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gomintia authorised in Switzerland?
Yes. Gomintia is authorised by Swissmedic under authorisation number 70542, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gomintia have?
Gomintia is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gomintia?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.